Salvage radiotherapy with prostate-specific membrane antigen-directed focal boost: A precision approach for recurrent prostate cancer
PSMA PET-guided salvage radiotherapy is an effective and personalized strategy for patients with biochemically recurrent prostate cancer. Compared with ADT alone, it provides superior failure-free survival with manageable toxicity, supporting its role as a standard component of salvage management.
Authors
- Yu‐Wen Hu (ORCID: https://orcid.org/0000-0002-7983-415X)
- Ko-Han Lin (ORCID: https://orcid.org/0000-0002-1464-3483)
- Yu‐Mei Kang (ORCID: https://orcid.org/0000-0001-8833-7457)
- Shu-Huei Shen (ORCID: https://orcid.org/0000-0002-5871-3092)
- Yuming Liu (ORCID: https://orcid.org/0000-0002-3656-7741)
- Tzu-Chun Wei
- Hsiao-Jen Chung (ORCID: https://orcid.org/0000-0003-4865-1251)
- Tien-Li Lan
- Tzu-Yu Lai
Institutions
- National Yang Ming Chiao Tung University (TW)
- Taipei Veterans General Hospital (TW)
- Taichung Veterans General Hospital (TW)
- Chung Shan Medical University (TW)
Publication Details
- Journal
- Journal of the Chinese Medical Association
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1097/jcma.0000000000001298
- Citations
- 4
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 6.07